{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T07:20:53Z","timestamp":1780384853853,"version":"3.54.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL132287"],"award-info":[{"award-number":["R01HL132287"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL132287"],"award-info":[{"award-number":["R01HL132287"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL132287"],"award-info":[{"award-number":["R01HL132287"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL132287"],"award-info":[{"award-number":["R01HL132287"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL132287"],"award-info":[{"award-number":["R01HL132287"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL132287"],"award-info":[{"award-number":["R01HL132287"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL132287"],"award-info":[{"award-number":["R01HL132287"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The aminopeptidase activity (AP) of the leukotriene A<jats:sub>4<\/jats:sub> hydrolase (LTA<jats:sub>4<\/jats:sub>H) enzyme has emerged as a therapeutic target to modulate host immunity. Initial reports focused on the benefits of augmenting the LTA<jats:sub>4<\/jats:sub>H AP activity and clearing its putative pro-inflammatory substrate Pro-Gly-Pro (PGP). However, recent reports have introduced substantial complexity disconnecting the LTA<jats:sub>4<\/jats:sub>H modulator 4-methoxydiphenylmethane (4MDM) from PGP as follows: (1) 4MDM inhibits PGP hydrolysis and subsequently inhibition of LTA<jats:sub>4<\/jats:sub>H AP activity, and (2) 4MDM activates the same enzyme target in the presence of alternative substrates. Differential modulation of LTA<jats:sub>4<\/jats:sub>H by 4MDM was probed in a murine model of acute lung inflammation, which showed that 4MDM modulates the host neutrophilic response independent of clearing PGP. X-ray crystallography showed that 4MDM and PGP bind at the zinc binding pocket and no allosteric binding was observed. We then determined that 4MDM modulation is not dependent on the allosteric binding of the ligand, but on the N-terminal side chain of the peptide. In conclusion, our study revealed that a peptidase therapeutic target can interact with its substrate and ligand in complex biochemical mechanisms. This raises an important consideration when ligands are designed to explain some of the unpredictable outcomes observed in therapeutic discovery targeting LTA<jats:sub>4<\/jats:sub>H.<\/jats:p>","DOI":"10.1038\/s41598-022-13238-6","type":"journal-article","created":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T11:03:34Z","timestamp":1654686214000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Substrate-dependent modulation of the leukotriene A4 hydrolase aminopeptidase activity and effect in a murine model of acute lung inflammation"],"prefix":"10.1038","volume":"12","author":[{"given":"Kyung Hyeon","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia Fazal","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Hyeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Burdick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary J.","family":"Beaulac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Petruncio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangdong","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezra M.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth W.","family":"Foreman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Schroeder M.","family":"Noble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun M.","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikell","family":"Paige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,8]]},"reference":[{"key":"13238_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0262-1746(82)90067-1","volume":"9","author":"B Samuelsson","year":"1982","unstructured":"Samuelsson, B. The leukotrienes: an introduction. Adv. Prostaglandin Thromboxane Leukot. Res. 9, 1\u201317 (1982).","journal-title":"Adv. Prostaglandin Thromboxane Leukot. Res."},{"key":"13238_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/BF01959134","volume":"4","author":"FP Nijkamp","year":"1982","unstructured":"Nijkamp, F. P. & Sitsen, J. M. A. Leukotrienes, allergy and inflammation. Pharm. Weekbl. Sci. 4, 165\u2013171 (1982).","journal-title":"Pharm. Weekbl. Sci."},{"key":"13238_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2174\/1568010023344643","volume":"1","author":"J Corless","year":"2002","unstructured":"Corless, J. & Paracha, M. The use of leukotriene modifying drugs in asthma and other respiratory diseases. Curr. Drug Target Inflamm. Allergy 1, 271\u2013275 (2002).","journal-title":"Curr. Drug Target Inflamm. Allergy"},{"key":"13238_CR4","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1172\/JCI111612","volume":"74","author":"TH Lee","year":"1984","unstructured":"Lee, T. H. et al. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils. J. Clin. Invest. 74, 1922\u20131933 (1984).","journal-title":"J. Clin. Invest."},{"key":"13238_CR5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1126\/science.1190594","volume":"330","author":"RJ Snelgrove","year":"2010","unstructured":"Snelgrove, R. J. et al. A critical role for LTA4H in limiting chronic pulmonary neutrophilic inflammation. Science 330, 90\u201394 (2010).","journal-title":"Science"},{"key":"13238_CR6","doi-asserted-by":"publisher","first-page":"5059","DOI":"10.4049\/jimmunol.1400452","volume":"192","author":"M Paige","year":"2014","unstructured":"Paige, M. et al. Role of leukotriene A4 hydrolase aminopeptidase in the pathogenesis of emphysema. J. Immunol. 192, 5059\u20135068 (2014).","journal-title":"J. Immunol."},{"key":"13238_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1164\/rccm.201405-0975ED","volume":"190","author":"R Snelgrove","year":"2014","unstructured":"Snelgrove, R. & Kheradmand, F. Leukotriene A4 hydrolase: the janus enzyme shows its ugly side in smokers. Am. J. Respir. Crit. Care Med. 190, 5\u20137 (2014).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"13238_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1164\/rccm.201401-0145OC","volume":"190","author":"JM Wells","year":"2014","unstructured":"Wells, J. M. et al. An aberrant leukotriene A4 hydrolase\u2013proline-glycine-proline pathway in the pathogenesis of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 190, 51\u201361 (2014).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"13238_CR9","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1021\/bi00132a010","volume":"31","author":"L Orning","year":"1992","unstructured":"Orning, L. & Fitzpatrick, F. A. Albumins activate peptide hydrolysis by the bifunctional enzyme LTA4 hydrolase\/aminopeptidase. Biochemistry 31, 4218\u20134223 (1992).","journal-title":"Biochemistry"},{"key":"13238_CR10","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/j.1365-2133.1995.tb02749.x","volume":"133","author":"JB Nissen","year":"2006","unstructured":"Nissen, J. B., Iversen, L. & Kragballe, K. Characterization of the aminopeptidase activity of epidermal leukotriene A4 hydrolase against the opioid dynorphin fragment 1\u20137. Br. J. Dermatol. 133, 742\u2013749 (2006).","journal-title":"Br. J. Dermatol."},{"key":"13238_CR11","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/0090-6980(92)90018-O","volume":"44","author":"KJ Griffin","year":"1992","unstructured":"Griffin, K. J., Fitzpatrick, F. A., Gierse, J. & Krivi, G. Opioid peptides are substrates for the bifunctional enzyme LTA4 hydrolase\/aminopeptidase. Prostaglandins 44, 251\u2013257 (1992).","journal-title":"Prostaglandins"},{"key":"13238_CR12","doi-asserted-by":"publisher","DOI":"10.5772\/25595","volume-title":"Inflammatory Diseases \u2013 Immunopathology, Clinical and Pharmacological Bases","author":"Y Michael","year":"2012","unstructured":"Michael, Y. & Paige, M. Leukotriene A4 hydrolase: an evolving therapeutic target. In Inflammatory Diseases \u2013 Immunopathology, Clinical and Pharmacological Bases (ed. Khatami, M.) (InTech, 2012). https:\/\/doi.org\/10.5772\/25595."},{"key":"13238_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/84117","volume":"8","author":"MMGM Thunnissen","year":"2001","unstructured":"Thunnissen, M. M. G. M., Nordlund, P. & Haeggstr\u00f6m, J. Z. Crystal structure of human leukotriene A4 hydrolase, a bifunctional enzyme in inflammation. Nat. Struct. Biol. 8, 131\u2013135 (2001).","journal-title":"Nat. Struct. Biol."},{"key":"13238_CR14","doi-asserted-by":"publisher","first-page":"44449","DOI":"10.1038\/srep44449","volume":"7","author":"CM Low","year":"2017","unstructured":"Low, C. M. et al. The development of novel LTA4H modulators to selectively target LTB4 generation. Sci. Rep. 7, 44449 (2017).","journal-title":"Sci. Rep."},{"key":"13238_CR15","doi-asserted-by":"publisher","first-page":"4694","DOI":"10.1021\/jm900259h","volume":"52","author":"DR Davies","year":"2009","unstructured":"Davies, D. R. et al. Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography\u2020. J. Med. Chem. 52, 4694\u20134715 (2009).","journal-title":"J. Med. Chem."},{"key":"13238_CR16","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1136\/thoraxjnl-2011-200234","volume":"66","author":"RJ Snelgrove","year":"2011","unstructured":"Snelgrove, R. J. Leukotriene A4 hydrolase: an anti-inflammatory role for a proinflammatory enzyme. Thorax 66, 550\u2013551 (2011).","journal-title":"Thorax"},{"key":"13238_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1465-9921-10-38","volume":"10","author":"P O\u2019Reilly","year":"2009","unstructured":"O\u2019Reilly, P. et al. N-\u03b1-PGP and PGP, potential biomarkers and therapeutic targets for COPD. Respir. Res. 10, 38 (2009).","journal-title":"Respir. Res."},{"key":"13238_CR18","doi-asserted-by":"publisher","first-page":"L1095","DOI":"10.1152\/ajplung.00040.2015","volume":"308","author":"M Abdul Roda","year":"2015","unstructured":"Abdul Roda, M. et al. The matrikine PGP as a potential biomarker in COPD. Am. J. Physiol. Lung Cell. Mol. Physiol. 308, L1095\u2013L1101 (2015).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"13238_CR19","doi-asserted-by":"publisher","first-page":"13591","DOI":"10.1038\/s41598-017-13490-1","volume":"7","author":"S Numao","year":"2017","unstructured":"Numao, S. et al. Feasibility and physiological relevance of designing highly potent aminopeptidase-sparing leukotriene A4 hydrolase inhibitors. Sci. Rep. 7, 13591 (2017).","journal-title":"Sci. Rep."},{"key":"13238_CR20","doi-asserted-by":"publisher","first-page":"6746","DOI":"10.1016\/j.bmcl.2011.09.048","volume":"21","author":"EO De Oliveira","year":"2011","unstructured":"De Oliveira, E. O. et al. Effect of the leukotriene A4 hydrolase aminopeptidase augmentor 4-methoxydiphenylmethane in a pre-clinical model of pulmonary emphysema. Bioorg. Med. Chem. Lett. 21, 6746\u20136750 (2011).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"13238_CR21","doi-asserted-by":"publisher","first-page":"L255","DOI":"10.1152\/ajplung.00304.2010","volume":"300","author":"S Braber","year":"2011","unstructured":"Braber, S. et al. Cigarette smoke-induced lung emphysema in mice is associated with prolyl endopeptidase, an enzyme involved in collagen breakdown. Am. J. Physiol. Lung Cell. Mol. Physiol. 300, L255\u2013L265 (2011).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"13238_CR22","doi-asserted-by":"publisher","first-page":"11269","DOI":"10.1016\/S0021-9258(19)78120-4","volume":"269","author":"L Orning","year":"1994","unstructured":"Orning, L., Gierse, J. K. & Fitzpatrick, F. A. The bifunctional enzyme leukotriene-A4 hydrolase is an arginine aminopeptidase of high efficiency and specificity. J. Biol. Chem. 269, 11269\u201311273 (1994).","journal-title":"J. Biol. Chem."},{"key":"13238_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-7091-1402-5","volume-title":"Kinetics of Enzyme-Modifier Interactions","author":"A Baici","year":"2015","unstructured":"Baici, A. Kinetics of Enzyme-Modifier Interactions (Springer, 2015). https:\/\/doi.org\/10.1007\/978-3-7091-1402-5."},{"key":"13238_CR24","first-page":"368","volume":"29","author":"Y Lin","year":"2001","unstructured":"Lin, Y. et al. Substrate inhibition kinetics for cytochrome P450-catalyzed reactions. Drug Metab. Dispos. Biol. Fate Chem. 29, 368\u2013374 (2001).","journal-title":"Drug Metab. Dispos. Biol. Fate Chem."},{"key":"13238_CR25","doi-asserted-by":"publisher","first-page":"10605","DOI":"10.1021\/acs.jmedchem.9b00663","volume":"62","author":"KH Lee","year":"2019","unstructured":"Lee, K. H. et al. Effect of modifier structure on the activation of leukotriene A4 hydrolase aminopeptidase activity. J. Med. Chem. 62, 10605\u201310616 (2019).","journal-title":"J. Med. Chem."},{"key":"13238_CR26","doi-asserted-by":"publisher","first-page":"50639","DOI":"10.1074\/jbc.R400027200","volume":"279","author":"JZ Haeggstr\u00f6m","year":"2004","unstructured":"Haeggstr\u00f6m, J. Z. Leukotriene A4 hydrolase\/aminopeptidase, the gatekeeper of chemotactic leukotriene B4 biosynthesis. J. Biol. Chem. 279, 50639\u201350642 (2004).","journal-title":"J. Biol. Chem."},{"key":"13238_CR27","doi-asserted-by":"publisher","first-page":"4227","DOI":"10.1073\/pnas.1402136111","volume":"111","author":"A Stsiapanava","year":"2014","unstructured":"Stsiapanava, A. et al. Binding of Pro-Gly-Pro at the active site of leukotriene A4 hydrolase\/aminopeptidase and development of an epoxide hydrolase selective inhibitor. Proc. Natl. Acad. Sci. 111, 4227\u20134232 (2014).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"13238_CR28","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1073\/pnas.072090099","volume":"99","author":"PC Rudberg","year":"2002","unstructured":"Rudberg, P. C., Tholander, F., Thunnissen, M. M. G. M., Samuelsson, B. & Haeggstrom, J. Z. Leukotriene A4 hydrolase: Selective abrogation of leukotriene B4 formation by mutation of aspartic acid 375. Proc. Natl. Acad. Sci. 99, 4215\u20134220 (2002).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"13238_CR29","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2353\/ajpath.2008.080081","volume":"173","author":"M Lin","year":"2008","unstructured":"Lin, M. et al. Matrix metalloproteinase-8 facilitates neutrophil migration through the corneal stromal matrix by collagen degradation and production of the chemotactic peptide Pro-Gly-Pro. Am. J. Pathol. 173, 144\u2013153 (2008).","journal-title":"Am. J. Pathol."},{"key":"13238_CR30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jneuroim.2009.09.020","volume":"217","author":"PJ O\u2019Reilly","year":"2009","unstructured":"O\u2019Reilly, P. J. et al. Neutrophils contain prolyl endopeptidase and generate the chemotactic peptide, PGP, from collagen. J. Neuroimmunol. 217, 51\u201354 (2009).","journal-title":"J. Neuroimmunol."},{"key":"13238_CR31","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.chembiol.2008.07.018","volume":"15","author":"F Tholander","year":"2008","unstructured":"Tholander, F. et al. Structure-based dissection of the active site chemistry of leukotriene A4 hydrolase: implications for M1 aminopeptidases and inhibitor design. Chem. Biol. 15, 920\u2013929 (2008).","journal-title":"Chem. Biol."},{"key":"13238_CR32","doi-asserted-by":"publisher","first-page":"e41063","DOI":"10.1371\/journal.pone.0041063","volume":"7","author":"S Thangapandian","year":"2012","unstructured":"Thangapandian, S., John, S., Lazar, P., Choi, S. & Lee, K. W. Structural origins for the loss of catalytic activities of bifunctional human LTA4H revealed through molecular dynamics simulations. PLoS ONE 7, e41063 (2012).","journal-title":"PLoS ONE"},{"key":"13238_CR33","doi-asserted-by":"publisher","first-page":"L749","DOI":"10.1152\/ajplung.00116.2010","volume":"299","author":"YM Shim","year":"2010","unstructured":"Shim, Y. M. et al. Role of LTB4 in the pathogenesis of elastase-induced murine pulmonary emphysema. Am. J. Physiol. Lung Cell. Mol. Physiol. 299, L749\u2013L759 (2010).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"13238_CR34","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.bbagen.2010.06.009","volume":"1800","author":"L Englert","year":"2010","unstructured":"Englert, L. et al. Displacement of disordered water molecules from hydrophobic pocket creates enthalpic signature: Binding of phosphonamidate to the S1\u2019-pocket of thermolysin. Biochim. Biophys. Acta (BBA) Gen. Subj. 1800, 1192\u20131202 (2010).","journal-title":"Biochim. Biophys. Acta (BBA) Gen. Subj."},{"key":"13238_CR35","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1016\/j.febslet.2010.06.044","volume":"584","author":"F Tholander","year":"2010","unstructured":"Tholander, F., Roques, B.-P., Fourni\u00e9-Zaluski, M.-C., Thunnissen, M. M. G. M. & Haeggstr\u00f6m, J. Z. Crystal structure of leukotriene A 4 hydrolase in complex with kelatorphan, implications for design of zinc metallopeptidase inhibitors. FEBS Lett. 584, 3446\u20133451 (2010).","journal-title":"FEBS Lett."},{"issue":"Suppl 1","key":"13238_CR36","first-page":"S49","volume":"29","author":"DA Armbruster","year":"2008","unstructured":"Armbruster, D. A. & Pry, T. Limit of blank, limit of detection and limit of quantitation. Clin. Biochem. Rev. 29(Suppl 1), S49-52 (2008).","journal-title":"Clin. Biochem. Rev."},{"key":"13238_CR37","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/00003226-200005000-00025","volume":"19","author":"RR Pfister","year":"2000","unstructured":"Pfister, R. R. et al. Synthetic complementary peptides inhibit a neutrophil chemoattractant found in the alkali-injured cornea. Cornea 19, 384\u2013389 (2000).","journal-title":"Cornea"},{"key":"13238_CR38","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nm1361","volume":"12","author":"NM Weathington","year":"2006","unstructured":"Weathington, N. M. et al. A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nat. Med. 12, 317\u2013323 (2006).","journal-title":"Nat. Med."},{"key":"13238_CR39","doi-asserted-by":"publisher","first-page":"L224","DOI":"10.1152\/ajplung.00423.2004","volume":"289","author":"TG Brock","year":"2005","unstructured":"Brock, T. G. et al. Nuclear localization of leukotriene A4 hydrolase in type II alveolar epithelial cells in normal and fibrotic lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 289, L224-232 (2005).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"13238_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4103\/2229-5186.79345","volume":"2","author":"A Shrivastava","year":"2011","unstructured":"Shrivastava, A. & Gupta, V. Methods for the determination of limit of detection and limit of quantitation of the analytical methods. Chron. Young Sci. 2, 21 (2011).","journal-title":"Chron. Young Sci."},{"key":"13238_CR41","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/1471-2105-11-395","volume":"11","author":"T Pluskal","year":"2010","unstructured":"Pluskal, T., Castillo, S., Villar-Briones, A. & Ore\u0161i\u010d, M. MZmine 2: Modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinform. 11, 395 (2010).","journal-title":"BMC Bioinform."},{"key":"13238_CR42","doi-asserted-by":"publisher","first-page":"180017","DOI":"10.1183\/16000617.0017-2018","volume":"27","author":"DF Patel","year":"2018","unstructured":"Patel, D. F. & Snelgrove, R. J. The multifaceted roles of the matrikine Pro-Gly-Pro in pulmonary health and disease. Eur. Respir. Rev. 27, 180017 (2018).","journal-title":"Eur. Respir. Rev."},{"key":"13238_CR43","doi-asserted-by":"publisher","first-page":"5243","DOI":"10.1016\/j.bmc.2016.08.047","volume":"24","author":"SK Wittmann","year":"2016","unstructured":"Wittmann, S. K. et al. Thermodynamic properties of leukotriene A 4 hydrolase inhibitors. Bioorg. Med. Chem. 24, 5243\u20135248 (2016).","journal-title":"Bioorg. Med. Chem."},{"key":"13238_CR44","doi-asserted-by":"publisher","first-page":"9689","DOI":"10.1073\/pnas.1710850114","volume":"114","author":"A Stsiapanava","year":"2017","unstructured":"Stsiapanava, A., Samuelsson, B. & Haeggstr\u00f6m, J. Z. Capturing LTA 4 hydrolase in action: insights to the chemistry and dynamics of chemotactic LTB 4 synthesis. Proc. Natl. Acad. Sci. USA 114, 9689\u20139694 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"13238_CR45","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1021\/acs.jmedchem.0c01955","volume":"64","author":"C Markert","year":"2021","unstructured":"Markert, C. et al. Discovery of LYS006, a potent and highly selective inhibitor of leukotriene A4 hydrolase. J. Med. Chem. 64, 1889\u20131903 (2021).","journal-title":"J. Med. Chem."},{"key":"13238_CR46","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1002\/cbic.200900788","volume":"11","author":"X Jiang","year":"2010","unstructured":"Jiang, X. et al. Modulating the substrate specificity of LTA4H aminopeptidase by using chemical compounds and small-molecule-guided mutagenesis. Chem. Eur. J. Chem. Bio. 11, 1120\u20131128 (2010).","journal-title":"Chem. Eur. J. Chem. Bio."},{"key":"13238_CR47","doi-asserted-by":"publisher","first-page":"6549","DOI":"10.1016\/j.bmcl.2008.10.044","volume":"18","author":"X Jiang","year":"2008","unstructured":"Jiang, X. et al. Activation and inhibition of leukotriene A4 hydrolase aminopeptidase activity by diphenyl ether and derivatives. Bioorg. Med. Chem. Lett. 18, 6549\u20136552 (2008).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"13238_CR48","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1164\/ajrccm.161.supplement_1.ltta-6","volume":"161","author":"JZ Haeggstr\u00f6m","year":"2000","unstructured":"Haeggstr\u00f6m, J. Z. Structure, function, and regulation of leukotriene A4 hydrolase. Am. J. Respir. Crit. Care Med. 161, S25\u2013S31 (2000).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"13238_CR49","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1749-6632.1994.tb52721.x","volume":"744","author":"FA Fitzpatrick","year":"1994","unstructured":"Fitzpatrick, F. A., Lepley, R., Orning, L. & Duffin, K. Suicide inactivation of leukotriene A4 hydrolase\/aminopeptidase. Ann. NY Acad. Sci. 744, 31\u201338 (1994).","journal-title":"Ann. NY Acad. Sci."},{"key":"13238_CR50","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/s00726-014-1694-2","volume":"46","author":"A Byzia","year":"2014","unstructured":"Byzia, A., Haeggstr\u00f6m, J. Z., Salvesen, G. S. & Drag, M. A remarkable activity of human leukotriene A4 hydrolase (LTA4H) toward unnatural amino acids. Amino Acids 46, 1313\u20131320 (2014).","journal-title":"Amino Acids"},{"key":"13238_CR51","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1016\/0960-894X(95)00441-U","volume":"5","author":"TD Penning","year":"1995","unstructured":"Penning, T. D. et al. Kelatorphan and related analogs: potent and selective inhibitors of leukotriene A4 hydrolase. Bioorg. Med. Chem. Lett. 5, 2517\u20132522 (1995).","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"8","key":"13238_CR52","doi-asserted-by":"publisher","first-page":"5662","DOI":"10.4049\/jimmunol.180.8.5662","volume":"180","author":"A Gaggar","year":"2008","unstructured":"Gaggar, A. et al. A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation. J. Immonol. 180(8), 5662\u20135669 (2008).","journal-title":"J. Immonol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13238-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13238-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13238-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T03:46:39Z","timestamp":1669347999000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13238-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,8]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["13238"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-13238-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,8]]},"assertion":[{"value":"30 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"YMS and MP are co-inventors of Patent Application US13\/814,087 entitled Compositions and Methods for Treating Inflammatory Disease, which includes 4MDM. KHL, GP, SMN, and MP\u2019s works have been funded by NIH R01HL132287. ZZ, MB, and YMS\u2019s works have been funded by NIH R01HL132177, NIH R01HL132287, NIH K08HL091127. NA, SHL, ZB, LL, JDX, EMC, and KWF declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9443"}}